InvestSMART

The article you are trying to access does not exist, however, here are some articles you may be interested in.

Apiam Animal Health Limited (ASX: AHX) - Announcements

DELISTED - Current share price for AHX : $0.875

ASX company news and announcements for Apiam Animal Health Limited (AHX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Apiam Animal Health Limited (AHX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Apiam Animal Health Limited (AHX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Apiam Animal Health Limited (AHX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Notification regarding unquoted securities - AHX 24 Mar 2023 8:44AM $0.540 $0.875 risen by 62.04%
- H1 FY23 Results Release 23 Feb 2023 8:08PM $0.620 $0.875 risen by 41.13%
- H1 FY23 Investor Presentation 23 Feb 2023 8:08PM $0.620 $0.875 risen by 41.13%
- Half Yearly Report and Accounts 23 Feb 2023 8:07PM $0.620 $0.875 risen by 41.13%
- H1 FY23 Reporting Date and Investor Webinar Notification 20 Feb 2023 8:29AM $0.620 $0.875 risen by 41.13%
- Application for quotation of securities - AHX 3 Feb 2023 9:23AM $0.635 $0.875 risen by 37.80%
- Application for quotation of securities - AHX 1 Feb 2023 4:17PM $0.620 $0.875 risen by 41.13%
- Proposed issue of securities - AHX 30 Jan 2023 9:50AM $0.615 $0.875 risen by 42.28%
- Strategic NSW acquisitions into two new high-growth regions 30 Jan 2023 8:45AM $0.615 $0.875 risen by 42.28%
- Change of Director's Interest Notice C Richards 20 Jan 2023 9:30AM $0.610 $0.875 risen by 43.44%
- Notification regarding unquoted securities - AHX 20 Jan 2023 9:28AM $0.610 $0.875 risen by 43.44%
- Proposed issue of securities - AHX 5 Jan 2023 4:27PM $0.630 $0.875 risen by 38.89%
- Notification of cessation of securities - AHX 3 Jan 2023 4:14PM $0.640 $0.875 risen by 36.72%
- Application for quotation of securities - AHX 12 Dec 2022 8:42AM $0.665 $0.875 risen by 31.58%
- Completion of Hunter Equine Centre Acquisition 12 Dec 2022 8:40AM $0.665 $0.875 risen by 31.58%
- Notification regarding unquoted securities - AHX 5 Dec 2022 4:12PM $0.670 $0.875 risen by 30.60%
- Proposed issue of securities - AHX 2 Dec 2022 11:25AM $0.700 $0.875 risen by 25%
- Acquisition of Hunter Equine Centre 1 Dec 2022 3:43PM $0.700 $0.875 risen by 25%
- Final Director's Interest Notice Van Blommestein 25 Nov 2022 8:26AM $0.705 $0.875 risen by 24.11%
- Amendment to the Constitution 24 Nov 2022 5:41PM $0.705 $0.875 risen by 24.11%
- Results of Annual General Meeting 24 Nov 2022 11:12AM $0.705 $0.875 risen by 24.11%
- Managing Director's Address to the Annual General Meeting 24 Nov 2022 8:23AM $0.680 $0.875 risen by 28.68%
- Chairman's Address to the Annual General Meeting 24 Nov 2022 8:23AM $0.680 $0.875 risen by 28.68%
- Release of securities from voluntary escrow 23 Nov 2022 4:24PM $0.680 $0.875 risen by 28.68%
- Cleansing Notice 9 Nov 2022 5:09PM $0.720 $0.875 risen by 21.53%

151 - 175 of 617 results

Page 7 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.